Eli Lilly & Co. said Monday the U.S. Food and Drug Administration has issued a complete response letter for its lebrikizumab, a treatment for...
Eli Lilly & Co. said Monday the U.S. Food and Drug Administration has issued a complete response letter for its lebrikizumab, a treatment for moderate-to-severe atopic dermatitis, after an inspection at a third-party manufacturer.
The letter, which means the FDA cannot approve the drug for now, was based on findings from an inspection of a plant that included the monoclonal antibody drug substance for Lilly’s lebrikizumab. “The letter stated no concerns about the clinical data package, safety or label for lebrikizumab,” said Lilly, which is confident the data support its submission package for the medicine. The stock LLY, -1.34% fell 0.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
These are the top 4 Club stocks — and the bottom 4 — during the third quarterEli Lilly (LLY) was the best-performing Club stock over the past three months, while Foot Locker (FL) was the worst in Q3.
Read more »
Lifetime premieres “Amish Stud: The Eli Weaver Story,” based on a true story (9/30/23)“Amish Stud: The Eli Weaver Story” will premiere Saturday, September 30 at 8 p.m. on Lifetime channel. Here's how to stream online, without cable.
Read more »
Monday’s Digital Daily: October 2, 2023Monday’s Digital Daily: October 2, 2023
Read more »
Tropical Storm Philippe threatens flash floods Monday in Leeward Islands, forecasters sayForecasts say Tropical Storm Philippe is threatening to unleash heavy rains and flash floods in the Leeward Islands. The U.S.
Read more »
Tropical Storm Philippe threatens flash floods Monday in Leeward Islands, forecasters sayForecasts say Tropical Storm Philippe is threatening to unleash heavy rains and flash floods in the Leeward Islands
Read more »